Skip to main content
. 2005 Dec 1;55(521):944–948.

Table 2.

Differences in terms of level of accuracy: profile, control and management factors (patients not using insulin), n = 85.

Underestimators (n = 37) Accurate (n = 36) Overestimators (n = 12) F/χ2 P-value
Profile
 Management
  Diet only (%) 13 (35.1) 12 (33.3) 3 (25) 4.12 0.390
  Tablet (%) 24 (64.8) 24 (66.7) 9 (75)
 Age, years (CI) 66.40 (62.5 to 69.2) 64.59 (61.0 to 69.2) 62.83 (55.9 to 69.8) 0.576 0.750
 Sex
  Male (%) 19 (51.3) 23 (63.8) 10 (83.3)
  Female (%) 18 (54.5) 13 (36.1) 2 (16.6) 3.042 0.081
 Time since diagnosis, years (CI) 4.13 (2.8 to 5.1) 5.75 (3.7 to 7.2) 5.25 (2.7 to 7.7) 1.424 0.491

Control
 Measured glucose (CI) 11.31 (10.1 to 12.3) 7.78 (7.2 to 8.3) 8.13 (5.4 to 10.7) 29.980 0.001
 HbA1C mean, last 2 years (CI) 7.95 (7.5 to 8.4) 7.36 (7.0 to 7.8) 7.56 (6.5 to 8.6) 4.145 0.126
 HbA1C, most recent (CI) 7.88 (7.5 to 8.2) 7.40 (6.9 to 7.8) 7.87 (6.6 to 9.1) 3.875 0.144

Management
 Home testing (%) 12 (32.4) 14 (38.8) 2 (16.6) 16.011 0.001
 Strips per month, users only (CI) 4.31(1.7 to 6.5) 8.12 (1.9 to 14.8) 0.83 (−0.65 to 2.3) 2.674 0.263
 State at clinic (%) 26 (70.2) 29 (74.5) 6 (50.0)
  Random (%) 11 (29.7) 7 (19.4) 6 (50.0) 12.895 0.001